Rezultati - Pchejetski, Dmitri
- Showing 1 - 16 results of 16
-
1
-
2
-
3
-
4
-
5
-
6
-
7
-
8
-
9
-
10
Core shell lipid-polymer hybrid nanoparticles with combined docetaxel and molecular targeted therapy for the treatment of metastatic prostate cancer od Wang, Qi, Alshaker, Heba, Böhler, Torsten, Srivats, Shyam, Chao, Yimin, Cooper, Colin, Pchejetski, Dmitri
Izdano 2017Text -
11
-
12
-
13
Everolimus (RAD001) sensitizes prostate cancer cells to docetaxel by down-regulation of HIF-1α and sphingosine kinase 1 od Alshaker, Heba, Wang, Qi, Kawano, Yoshiaki, Arafat, Tawfiq, Böhler, Torsten, Winkler, Mathias, Cooper, Colin, Pchejetski, Dmitri
Izdano 2016Text -
14
Combination of RAD001 (everolimus) and docetaxel reduces prostate and breast cancer cell VEGF production and tumour vascularisation independently of sphingosine-kinase-1 od Alshaker, Heba, Wang, Qi, Böhler, Torsten, Mills, Robert, Winkler, Mathias, Arafat, Tawfiq, Kawano, Yoshiaki, Pchejetski, Dmitri
Izdano 2017Text -
15
Leptin induces upregulation of sphingosine kinase 1 in oestrogen receptor-negative breast cancer via Src family kinase-mediated, janus kinase 2-independent pathway od Alshaker, Heba, Krell, Jonathan, Frampton, Adam E, Waxman, Jonathan, Blyuss, Oleg, Zaikin, Alexey, Winkler, Mathias, Stebbing, Justin, Yagüe, Ernesto, Pchejetski, Dmitri
Izdano 2014Text -
16
Chromatin conformation changes in peripheral blood can detect prostate cancer and stratify disease risk groups od Alshaker, Heba, Mills, Robert, Hunter, Ewan, Salter, Matthew, Ramadass, Aroul, Skinner, Benjamin Matthew, Westra, Willem, Green, Jayne, Akoulitchev, Alexandre, Winkler, Mathias, Pchejetski, Dmitri
Izdano 2021Text